Podanie ▲ Držiteľ Kód Liek Účinnosť Predmet 9.3.2023 Teva Czech Industries s.r.o. (TEV-CZ-2) 4799C PLEUMOLYSIN (gto por 1x10 ml (fľ.skl.hnedá s bezpeč.uzáver.)) 9.3.2023 O 9.3.2023 Teva Czech Industries s.r.o. (TEV-CZ-2) 95520 TUSSIN (gto por 1x25 ml (fľ.skl.hnedá)) 9.3.2023 O 9.3.2023 Gedeon Richter Plc. (GDN) 71897 Lunaldin 200 mikrogramov sublingválne tablety (tbl slg 30x200 µg (blis.OPA/Al/PVC/papier/PE/Al)) 13.3.2023 O 9.3.2023 Gedeon Richter Plc. (GDN) 71901 Lunaldin 400 mikrogramov sublingválne tablety (tbl slg 30x400 µg (blis.OPA/Al/PVC/papier/PE/Al)) 13.3.2023 O 8.3.2023 Vipharm S.A. (VIH-PL-1) 66651 Derin 25 mg filmom obalené tablety (tbl flm 30(10x3)x25 mg (blis.PVC/Al)) 6.3.2023 O 8.3.2023 MEDOCHEMIE Ltd. (MOE) 33522 MEDOCLAV 625 mg (tbl flm 21x625 mg (blis.Al/PVC)) 10.3.2023 O 8.3.2023 KRKA, d.d., Novo mesto (KRK-2) 40543 Yasnal 10 mg (tbl flm 28x10 mg (blis.Al/OPA/Al/PVC)) 17.4.2023 R 8.3.2023 KRKA, d.d., Novo mesto (KRK-2) 4392C Betaklav 875 mg/125 mg filmom obalené tablety (tbl flm 20x875 mg/125 mg (blis.OPA/Al/PVC/Al)) 27.3.2023 R 8.3.2023 KRKA, d.d., Novo mesto (KRK-2) 9050D Maymetsi 50 mg/850 mg filmom obalené tablety (tbl flm 56x50 mg/850 mg (blis.PVC/PE/PVDC/PE/PVC/Al)) 8.3.2023 R 8.3.2023 KRKA, d.d., Novo mesto (KRK-2) 9052D Maymetsi 50 mg/850 mg filmom obalené tablety (tbl flm 196x50 mg/850 mg (blis.PVC/PE/PVDC/PE/PVC/Al)) 8.3.2023 R 8.3.2023 KRKA, d.d., Novo mesto (KRK-2) 9062D Maymetsi 50 mg/1000 mg filmom obalené tablety (tbl flm 56x50 mg/1000 mg (blis.PVC/PE/PVDC/PE/PVC/Al)) 8.3.2023 R 8.3.2023 KRKA, d.d., Novo mesto (KRK-2) 9065D Maymetsi 50 mg/1000 mg filmom obalené tablety (tbl flm 196x50 mg/1000 mg (blis.PVC/PE/PVDC/PE/PVC/Al)) 8.3.2023 R 8.3.2023 Laboratorios Salvat, S.A. (LBI) 2323A Infalin duo 3 mg/ml + 0,25 mg/ml ušná roztoková instilácia (int ots 1x10 ml (fľ.PE s kvapkadlom)) 8.3.2023 O 8.3.2023 G.L. Pharma GmbH (GLH-2) 0445D Neuromultivit filmom obalené tablety (tbl flm 50 (blis.Al/Al)) 6.3.2023 R 8.3.2023 Teva B.V. (TEV-NL-4) 5043D STOPTUSSIN tablety (tbl 1x30 (blis.Al/PVC)) 20.3.2023 R
